monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-CL interface
External Resource: Annotation
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| B [auth L] | e8ti4L1 | A: beta barrels | X: RNase A-like | H: RNase A-like | T: RNase A-like | F: | ECOD (v294.2) | |
| A [auth H] | e8ti4H1 | A: beta barrels | X: RNase A-like | H: RNase A-like | T: RNase A-like | F: | ECOD (v294.2) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-06-05) |
| A [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-06-05) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth L] | Nesfrotamig | ERBB2/CD340/HER2, TNFRSF9/CD137/4-1BB, SIRPA, CD3E | Therapeutic SAbDab (2026-06-05) |
| A [auth H] | Coprelotamab | ERBB2/CD340/HER2, CD3E, TNFRSF9/CD137/4-1BB, SIRPA | Therapeutic SAbDab (2026-06-05) |
